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The specific roles that immunoproteasome variants
play in MHC class I antigen presentation are
unknown at present. To investigate the biochemical
properties of different immunoproteasome forms
and unveil the molecular mechanisms of PA28 activ-
ity, we performed in vitro degradation of full-length
proteins by 20S, 26S, and PA28ab-20S immuno-
proteasomes and analyzed the spectrum of peptides
released. Notably, PA28ab-20S immunoprotea-
somes hydrolyze proteins at the same low rates as
20S alone, which is in line with PA28, neither stimu-
lating nor preventing entry of unfolded polypeptides
into the core particle. Most importantly, binding of
PA28ab to 20S greatly reduces the size of proteaso-
mal products and favors the release of specific, more
hydrophilic, longer peptides. Hence, PA28ab may
either allosterically modify proteasome active sites
or act as a selective ‘‘smart’’ sieve that controls the
efflux of products from the 20S proteolytic chamber.
INTRODUCTION
The continual presentation of intracellular protein fragments on
major histocompatibility complex (MHC) class I molecules is a
process that allows cytotoxic CD8+ T lymphocytes (CTLs) to
eliminate cells that synthesize foreign or abnormal proteins
(Pamer and Cresswell, 1998). The vast majority of MHC class
I-presented peptides are generated during the degradation of
mature proteins or defective ribosomal products by the ubiqui-
tin-proteasome system (UPS) (Rock and Goldberg, 1999; Yew-
dell, 2001). The active form of proteasome, which appears to
degrade most cellular proteins, is the 26S proteasome, a large
proteolytic complex formed by the association of the 19S regu-
latory particle with the 20S proteasome (Voges et al., 1999). In
most cells, the proteolytic activity of the 20S proteasome is
mediated by three subunits of the core particle: b5, b2, and b1.
However, lymphoid cells and cells exposed to cytokines such
as interferon g (IFN-g) express three alternative, homologous
subunits (b5i/LMP7, b2i/MECL-1, b1i/LMP2), which replace the470 Chemistry & Biology 21, 470–480, April 24, 2014 ª2014 Elsevierconstitutive active b-subunits in newly-assembled immunopro-
teasome particles (Kloetzel, 2001). The pivotal role of immuno-
proteasomes in the generation of MHC class I ligands was
recently demonstrated in transgenic mice lacking all three pro-
teasomal catalytic b-immune subunits (Kincaid et al., 2012).
Another IFN-g-inducible UPS component that affects MHC
class I antigen presentation is PA28, a ring-shaped heterohepta-
meric complex (3a4b) (Sugiyama et al., 2013) that can bind to the
20S proteasome and dramatically enhance its ability to degrade
short peptide substrates, but not ubiquitin-conjugated proteins
(Dubiel et al., 1992; Ma et al., 1992). In addition, PA28 can also
form an asymmetric 26S hybrid complex (19S-20S-PA28)
(Cascio et al., 2002; Hendil et al., 1998). The effects of PA28 on
antigen processing and CD8+ responses are still unclear and
controversial (Rechsteiner et al., 2000). Expression of PA28a or
PA28ab has been reported to enhanceMHC class I presentation
of some, but not all, antigens (Sijts et al., 2002). Furthermore,
cells lacking this complex have a reduced ability to generate
certain antigens (Murata et al., 2001). Recent studies have iden-
tified PA28 as the second most important UPS component for
the production of MHC class I ligands (de Graaf et al., 2011),
although its effects seem to be restricted to specific MHC class
I alleles (Yamano et al., 2008). Additionally, several studies have
indicated that oxidized proteins are preferentially degraded
without ubiquitination by 20S immunoproteasomes (Orlowski
and Wilk, 2003) in a process that may be stimulated by
PA28ab (Li et al., 2011; Pickering et al., 2010). A variety of
biochemical actions have been proposed for PA28 (Rechsteiner
et al., 2000; Stadtmueller and Hill, 2011), and the crystal struc-
ture of PA26 (PA28 homolog in trypanosomes) in association
with 20S yeast proteasomes has been solved (Whitby et al.,
2000). The binding of PA26was found to dilate the gated channel
in the proteasome a-ring through which substrates enter (Groll
et al., 2000) and products exit (Ko¨hler et al., 2001). Therefore,
PA28 was predicted to lead to attenuation of proteasomal proc-
essivity and consequent release of peptide products with a
greater mean length (Whitby et al., 2000), as occurs upon dele-
tion of the a-gate (Ko¨hler et al., 2001). A full understanding of
the molecular mechanism of PA28 activity would undoubtedly
represent an important achievement, especially in light of the
observation that mammalian cells contain significant amounts
of PA28ab-20S immunocomplexes (Ahn et al., 1996; Hendil
et al., 1998), whose abundance further increases upon IFN-g
stimulation (Murata et al., 2001; Tanahashi et al., 1997).Ltd All rights reserved
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Figure 1. Casein Degradation by 20S, 26S,
and PA28ab-20S Immunoproteasomes
(A and B) Primary NH2 generated by equimolar
amounts of immunoproteasomes were quantified
by fluorescamine and are expressed as fold
change relative to the amount released in 2 hr by
20S. (A) Equimolar amounts of 20S and 26S. (B)
Equimolar amounts of 20S and PA28ab-20S. The
average of four to six independent experiments
(±SEM) is shown. NH2 generation does not occur
when the substrate was incubated alone, with only
PA28ab or in the presence of b-lactone. *p < 0.05,
**p < 0.01. See also Figure S1.
(C) Casein was incubated as indicated in the figure,
and the undegraded protein was separated by
SDS-PAGE.
(D) Densitometric quantification of the residual
protein. Data are the average of three independent
experiments (±SEM). NS, not significant. *p < 0.05.
(E) FITC-casein was incubated with immuno-
proteasomes, and generation of soluble fluores-
cence was assessed. AU, arbitrary units.
(F) FITC-casein was degraded by immuno-
proteasomes, and peptides were analyzed by
RP-HPLC. See also Experimental Procedures.
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Different Immunoproteasome Species Exhibit Distinct
Rates of Peptide Bond Cleavage and Turnover of Protein
Substrates
In an attempt to further characterize the biochemical properties
of different forms of IFN-g-induced proteasomes, we incubated
casein for several hours with 26S, 20S, and 20S-PA28ab immu-
noproteasomes in a buffer containing ATP and Mg2+, and the
hydrolysis of the substrate was measured by fluorescamine
assay (Cascio et al., 2001; Kisselev et al., 1999). Under these
experimental conditions, proteasome species are completely
stable and maintain their structural integrity and biochemical
properties for several hours (Cascio et al., 2001; Kisselev et al.,
1999) (Figure S1A available online). As shown in Figures 1A
and 1B, the rates of generation of new amino groups were linear,
albeit widely different, for up to 6 hr for the three immunoprotea-
some species analyzed. Specifically, 26S immunoproteasomes
were found to generate 10-fold more amino groups than
20S immunoproteasomes (Figure 1A). Surprisingly, the 20S-
PA28ab complexes consistently generated 3-fold more aminoChemistry & Biology 21, 470–480, April 24, 2014groups at each time point than 20S
particles alone (Figure 1B). This obser-
vation was unexpected because PA28
has been described as an activator of
hydrolysis by the 20S particle of small
tri- and tetrapeptides (but not full-length
proteins) (Ma et al., 1992). In principle,
the higher generation rate of primary
amino groups by PA28abassociated
20S immunoproteasomes might result
from either accelerated protein break-
down induced by the activator or from a
modification in the pattern of peptideproducts released (i.e., even if the overall rate of substrate con-
sumption were not increased). To discriminate between these
two mechanisms, we initially followed the disappearance of
undigested casein incubated for several hours in the presence
of 20S immunoproteasomes alone or conjugated with PA28.
This experiment clearly demonstrated that the presence of
PA28ab does not modify the kinetics of substrate disappearance
(Figures 1C and 1D). The lack of increased substrate consump-
tion upon binding of PA28ab to the 20S core particle was sub-
sequently confirmed by assessing degradation of fluorescein
isothiocyanate (FITC)-labeled casein (Figure 1E). In this assay,
the fluorescence signal generated is directly proportional to the
rate of turnover of the substrate independently of the character-
istics of the peptides produced. As shown in Figure 1E, the rates
of appearance of trichloroacetic acid-soluble fluorescence were
identical when FITC-casein was degraded by either 20S or 20S-
PA28ab particles and were nearly 6-fold lower than rates
observed with 26S immunoproteasomes. We therefore con-
cluded that the association of PA28 with 20S immuno-
proteasomes does not alter the rate of casein and FITC-casein
hydrolysis. Accordingly, we tested whether PA28ab mightª2014 Elsevier Ltd All rights reserved 471
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Figure 2. IGF-1 Degradation by 20S, 26S,
and PA28ab-20S Immunoproteasomes
(A and B) Degradation of IGF-1 immuno-
proteasomes was performed as described in Fig-
ure 1. (A) Degradation by 20S and 26S. (B)
Degradation by 20S and PA28ab-20S. The
average of three independent experiments (±SEM)
is shown. *p < 0.05.
(C) IGF-1 was incubated as indicated, and the
undegraded protein was separated by SDS-PAGE.
(D) Densitometric quantification of the residual
protein. Data are the average of three independent
experiments (±SEM). NS, not significant. *p < 0.05.
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presumably by increasing the frequency of cleavage within the
20S core. Toward this end, we separated degradation products
by reverse phase high-performance liquid chromatography
(RP-HPLC), and the chromatographic profiles were compared.
Remarkably, the peptide patterns were dramatically different
depending on whether FITC-casein (Figure 1F) was degraded
by the 20S, 20S bound to PA28, or 26S immunoproteasomes.
In particular, although some peptides were produced by both
20S and 20S-PA28 particles, albeit in different amounts, several
others were detected only when one of these two immunopro-
teasome forms was used (Figure 1F).
To confirm these findings, we performed similar degradation
experiments with the 8 kDa protein insulin-like growth factor 1
(IGF-1), another well-characterized proteasome model sub-
strate. Similar to what has been observed for casein, the rates
of appearance of primary amino groups were 8-fold and 2-
fold higher than 20S particles for 26S and for 20S-PA28ab immu-
noproteasomes, respectively (Figures 2A and 2B). Importantly,
even for IGF-1, enhanced levels of peptide bond cleavage
induced by PA28 did not correspond to increased rates of sub-
strate turnover, but they did to a higher frequency of cleavage
events (Figures 2C and 2D).
20S-PA28ab Complexes Generate Shorter Peptide
Products than 20S and 26S Immunoproteasomes
Because the association of PA28ab with 20S particles did not
alter the rate of protein hydrolysis but did modify the pattern of
the peptides produced, we investigated the effect of this associ-
ation on the size distribution of proteasomal products. In fact,
because the observed increase in the rate of peptide bond cleav-
age does not result in enhanced substrate turnover, it must be
correlated with a reduction in the average size of peptide prod-472 Chemistry & Biology 21, 470–480, April 24, 2014 ª2014 Elsevier Ltd All rights reserveducts. To test this hypothesis, we incu-
bated casein and IGF-1 with the 20S,
20S-PA28ab, and 26S immunoprotea-
somes under conditions that ensure a
linear rate of peptide generation and do
not favor a second cycle of cleavage
following release from proteasomes (Cas-
cio et al., 2001; Kisselev et al., 1999). To
ensure such conditions, substrates were
present in large excess and no more
than 10% of the initial substrate wasconsumed (Figures S2A and S2B). After 6 hr, the peptides
produced were separated from the undigested substrate by
ultrafiltration through a 5 kDa membrane, derivatized with
fluorescamine, and fractionated by high-performance size
exclusion chromatography (HP-SEC) with online fluorescence
detection. This method provides a quantitative measure of
different products, as the intensity of the fluorescence signal
emitted by any peptide is the same and is independent of its
length (Berko et al., 2012; Ko¨hler et al., 2001). When analyzed
by this method, peptides generated from casein by the 20S
and 26S immunoproteasomes were found to fall into a contin-
uum of size distribution ranging from 1 to 26 residues (Figure 3A)
that appeared to fit a lognormal distribution, which is in agree-
ment with previous analyses of different substrates and protea-
some species (Cascio et al., 2001, 2002; Kisselev et al., 1999;
Ko¨hler et al., 2001). Specifically, the chromatographic profile of
20S particle products was characterized by four broad peaks
(Figure 3A, left panel) corresponding to lengths of 1 or 2, 3–5,
11–13, and 17–20 residues. The generation of detectable
amounts of products with a molecular weight of 200 Da was
unexpected because proteasomes have not been found to
generate such small fragments. It is possible that the analytical
approaches used previously either excluded or imposed a
strong bias against individual amino acids and dipeptides,
whereas the method we used in this study can accurately
separate and quantitate peptides between 1 and 30 residues
long (Figure S2C). A similar size distribution was also obtained
for the products of 26S immunoproteasomes, although in this
case the peak of the longer fragments was significantly reduced
and amatching increase was detected in the peaks correspond-
ing to the shorter peptides (Figure 3A, right panel). Con-
sequently, both the mean and median lengths of peptide
products were about two residues shorter for 26S than for 20S
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Figure 3. Size Distribution of Peptides
Generated from Casein and IGF-1 by 20S,
26S, and PA28ab-20S Immunoproteasomes
(A and B) Equal amounts of peptides generated
during degradation by 20S, 26S, and PA28ab-20S
immunoproteasomes were reacted with fluoresc-
amine and immediately fractionated by HP-SEC.
(A) Degradation of casein. (B) Degradation of
IGF-1. Similar data were obtained in at least four
independent experiments.
(C) The cumulative frequency curves of peptides
generated from casein and IGF-1 were obtained by
transformation of data shown in (A) and (B). For
each molecular weight, the fraction of peptides
with this molecular mass and lower was calcu-
lated, and each curve was obtained by averaging
the data from four independent experiments. See
also Figure S2 and Experimental Procedures.
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Differences in Products of Immunoproteasomesimmunoproteasomes (Table 1). However, the size distribution of
products generated by 20S-PA28ab immunoproteasomes
differed drastically from that of both 20S and 26S particles
(Figure 3A). Specifically, the peak corresponding to the longer
products disappeared, the peak of 11- to 13-residue peptides
was significantly reduced, and the two peaks of shorter frag-
ments increased in size. Consequently, the binding of PA28ab
to 20S proteasomes reduced themean andmedian sizes of pep-
tide products by about 50% (Table 1).
Similar results were subsequently obtained for the size distri-
butions of IGF-1 degradation products (Figure 3B). With this
shorter substrate, 20S immunoproteasomes were found to
generate the same four broad peaks of products we had already
observed for casein, although in this case the two central peaks
were higher than the peaks of longer and smaller fragments (Fig-
ure 3B, left panel). Furthermore, with 26S particles, the peak of
11–13 amino acids was also strongly reduced (Figure 3B, rightChemistry & Biology 21, 470–480, April 24, 2014panel), whereas with 20S-PA28ab immu-
noproteasomes, a major peak (corre-
sponding to three to five residues) was
detected and the peak of amino acids
and dipeptides slightly increased in size
compared to 20S and 26S (Figure 3B).
Accordingly, the mean and median prod-
uct lengths calculated from these size
distributions were higher for 20S than for
26S immunoproteasomes, whereas 20S-
PA28ab products were characterized by
lower mean and median values (Table 1).
To further analyze the relative distribu-
tions of peptides of different sizes, we
plotted these data as cumulative fre-
quency curves (Kisselev et al., 1999) (Fig-
ure 3C). The resulting size distribution
plots clearly showed that, for both protein
substrates, nomore than 10%of peptides
generated by the three forms of immuno-
proteasomes were eight to ten residues
long, which is the appropriate length to
bind MHC class I heterodimers (Figure 3Cand Table 2). Importantly, the association of PA28ab with the
20S particles did not increase this fraction, but slightly reduced
it (Table 2). Moreover, casein products that might serve in
MHC class I antigen presentation after appropriate trimming by
aminopeptidases in the cytosol or the endoplasmic reticulum
(ER) represent 38%, 24%, and 8% of the total when the protein
is degraded by 20S, 26S, and 20S-PA28ab immunoprotea-
somes, respectively (Figure 3C and Table 2). Similar results
were obtained for IGF-1, although with this smaller substrate
higher production of peptides shorter than eight residues were
detected for all three immunoproteasome species (Figure 3C
and Table 2).
Tandem Mass Spectrometry of Immunoproteasomal
Products
To further define changes in the patterns of products that re-
sulted from binding of PA28ab to 20S particles, and specificallyª2014 Elsevier Ltd All rights reserved 473
Table 2. Size Classes of Peptides Generated from IGF-1 and
Casein by Different Forms of Immunoproteasomes
Immunoproteasome Substrate
Fractions of Peptides (%)
<8 aa 8–10 aa >10 aa
20S IGF-1 67 9 24
casein 54 8 38
20S-PA28ab IGF-1 89 6 5
casein 86 6 8
26S IGF-1 78 9 13
casein 66 10 24
Peptide lengths were calculated using the product distributions obtained
by HP-SEC and grouped into three size classes to fit into the groove of
MHC class I molecules: longer (>10 aa), shorter (<8 aa), and of the correct
size (8–10 aa).
Table 1. MeanPeptideSizesGenerated by 20S, 20S-PA28ab, and
26S Immunoproteasomes from IGF-1 and Casein
Immunoproteasome Substrate Mean Median
20S IGF-1 7.3 ± 0.10 5.9 ± 0.07
casein 9.4 ± 0.14 7.3 ± 0.27
20S-PA28ab IGF-1 4.9 ± 0.07 4.6 ± 0.04
casein 4.8 ± 0.05 3.9 ± 0.07
26S IGF-1 6.0 ± 0.05 5.3 ± 0.06
casein 7.3 ± 0.04 5.7 ± 0.10
Mean sizes and medians were calculated using the product distributions
obtained by HP-SEC, assuming an average molecular weight of 110 Da
for each residue. Values are averages from five experiments (±SEM).
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between 20S, 20S-PA28ab, and 26S immunoproteasomes, the
individual peptides generated from IGF-1 and casein were
analyzed by tandem mass spectrometry (MS/MS). In the MS/
MS analysis, we excluded peptides with a length of up to seven
amino acids in order to minimize signals originating from small
chemical compounds. Although MS/MS does not provide
quantitative information about the absolute abundance of the
peptides detected, their relative amounts can be assessed by
comparing the corresponding ion intensities measured in
sequential MS/MS analyses (Bantscheff et al., 2007; Old et al.,
2005). Therefore, we used ion intensities to quantify the relative
amount of single fragments generated from IGF-1 and casein
by more than one immunoproteasome species. By using this
approach, 90 different peptides from IGF-1 and 103 from casein
were unambiguously identified and quantified (Figure 4). These
peptides ranged in length from 8 to 25 residues andwere derived
from the entire length of the proteins. Notably, the generation of
some of the peptides required the removal of one or two residues
from the substrate, further demonstrating that proteasomes can
release products as short as single amino acids and dipeptides.
Most importantly, this analysis demonstrated that, though some
peptides are generated exclusively by the 20S, 20S-PA28ab,
and/or 26S immunoproteasomes, several others are produced
in common by different immunoproteasome forms, but in very
different amounts. In fact, even if some products are released
at about the same level by two or even all three proteasome
species, many others are characterized by striking quantitative
differences spanning over three log values. Notably, regardless
of the clear differences in the overall sizes distributions of prod-
ucts unveiled by HP-SEC, the MS/MS data reveal that each of
the three immunoproteasome forms can preferentially enhance
the generation of individual peptides that are 8–25 residues in
length (Figure 4 and Table S1). These results were further
confirmed by the analysis of peptides generated by the asym-
metric 26S hybrid complex: namely, proteasomes capped at
one side by 19S regulatory particles and by PA28 at the other
(Cascio et al., 2002; Hendil et al., 1998). In this case, MS/MS
analysis revealed that hybrid particles generate some of the
peptides produced in common by 26S and PA28ab-20S from
IGF-1 and also several of those released specifically only by
one of the two immunoproteasome forms (Table S2).
To check whether the differences in the sequence of products
revealed by MS/MS analysis might be predicted at least in part474 Chemistry & Biology 21, 470–480, April 24, 2014 ª2014 Elsevieron the basis of the modifications of the three main proteasomal
peptidase activities induced by PA28, we assessed the stimula-
tory effect of PA28 on cleavage specificities of 20S particles. In
this way, we found that the caspase-like activity, although lower
in absolute terms, is the immunoproteasome peptidase activity
that is enhanced to a higher extent by PA28, whereas stimulation
of chymotryptic and tryptic activities appears to be lower and
more dependent on the specific sequence of the peptide used
(Figure 5A). It is interesting that this higher activation of cas-
pase-like activity may help to explain the enhanced generation
of peptides with an acidic residue at their C terminus that we
observed when IGF-1 and, to a lesser extent, casein are
degraded by 20S-PA28ab particles (Figure 4 and Table S1).
Furthermore, in an attempt to define the physiochemical pa-
rameters that control the generation of longer products in the
presence of PA28, we calculated the hydropathy of peptides
exclusively (or preferentially) released by 20S and PA28ab-20S
immunoproteasomes (Table S3). As expected for products
derived from two extremely hydrophilic proteins, such as IGF-1
and casein, both pools of peptides were characterized by high
average hydrophilicity. However, hydrophilicity was significantly
higher for peptides generated by PA28ab-20S immunoprotea-
somes (Figure 5B), suggesting that PA28might allow preferential
release of longer products that are polar and/or charged from the
proteolytic proteasomal chamber.
DISCUSSION
In the present study, we focused on immunoproteasomal de-
gradation of loosely folded, nonubiquitinated proteins, as ubiq-
uitinated proteins are not hydrolyzed by 20S and PA28-20S
complexes (Dubiel et al., 1992; Ma et al., 1992), most likely
because these particles lack the enzymatic activities necessary
to remove and/or to unfold polyubiquitin chains that otherwise
would sterically block translocation of substrates into the proteo-
lytic chamber (Shabek and Ciechanover, 2010; Yao and Cohen,
2002). As a result, we found that unstructured polypeptides are
hydrolyzed at rates that are nearly 10-fold higher by 26S
compared to 20S immunoproteasomes. This finding is consis-
tent with the notion that the free 20S particle is a relatively inac-
tive protease, presumably because the N-terminal tails of its a
subunits obstruct the two opposite axial pores through whichLtd All rights reserved
Chemistry & Biology
Differences in Products of Immunoproteasomessubstrates access the internal catalytic lumen (Groll et al., 2000).
This autoinhibited state is relieved when the 20S core particle
binds to activators, such as 19S or PA28, that displace the
N-terminal tails, thereby opening an axial channel in the a-ring
(Ko¨hler et al., 2001; Whitby et al., 2000). However, the latency
of unliganded 20S proteasome is not absolute, because, even
in the absence of artificial treatments that are known to activate
it (Coux et al., 1996), the 20S core particle degrades proteins at
detectable and reproducible rates, probably involving transient
and/or only partial channel opening (Ko¨hler et al., 2001). Accord-
ingly, atomic force microscopy studies have shown that the
a-rings of the 20S proteasome repeatedly switch between an
open and a closed gate conformation, and, importantly, the
relative abundance of the two conformers depends on the nature
of their interaction with ligands. In fact, the closed conformation
predominates in control or inhibited 20S proteasomes, whereas
the open form prevails in the presence of peptide or protein sub-
strates (Osmulski and Gaczynska, 2000, 2002; Osmulski et al.,
2009). Interestingly, despite the fact that the open-channel
conformation of the gating residues induced by ATP-dependent
(i.e., 19S) and ATP-independent (i.e., PA28) activators appears
to be identical (Rabl et al., 2008), our data show that PA28ab-20S
immunocomplexes hydrolyze proteins at the same rates as 20S
immunoproteasomes and much less efficiently than 26S immu-
noproteasomes. These results confirm the initial reports on the
biochemical properties of PA28 (Ma et al., 1992), but it appears
to be difficult to reconcile themwith the known role of the protea-
somal gate in controlling accessibility of substrates into the
lumen of the 20S particle. In fact, opening of the axial channel
by deletion of the N-terminal tails of eukaryotic (Ko¨hler et al.,
2001) or archaeal (Benaroudj et al., 2003) proteasomal a sub-
units results in strong enhancement of the degradation rates of
unfolded proteins, suggesting that unstructured substrates can
freely access the internal proteolytic chamber of the 20S particle
simply by passive diffusion thorough a fully open gate. In light of
these data, the inability of PA28 to enhance hydrolysis rates of
loosely folded proteins is surprising. In fact, the crystal structure
of PA28a shows that the aqueous channel through the heptamer
has a diameter of 20 A˚ at its minimum, which is at least in princi-
ple wide enough for passage of unfolded proteins (Knowlton
et al., 1997). However, the homolog-specific inserts present
between helices 1 and 2, which are not resolved in the crystal
structure, most likely form a ringlike collar on the upper, non-
proteasome binding surface of the PA28 heptamer. Although
several studies have shown that these loops do not restrict pas-
sage of tri- or tetrapeptide fluorogenic substrates (Song et al.,
1997; Zhang et al., 1998), recent investigations have demon-
strated that they can hinder the transit of longer peptides, and
conceivably of proteins as well, through the PA28 channel (Su-
giyama et al., 2013).
Although PA28ab does not enhance the rates of protein degra-
dation by proteasomes, its association with the 20S particle
leads to profound changes in the patterns of the generated
peptides, which greatly differ from those produced by 20S and
26S immunoproteasomes. In fact, from both protein substrates
analyzed, 20S and 26S immunoproteasomes were found to
release a continuum of peptides with a size ranging from 1 to
26 residues, although some classes of length clearly predomi-
nate. Surprisingly, PA28ab-20S immunoproteasomes display aChemistry & Biology 21,reduced ability to generate longer products that, in principle,
might depend upon different mechanisms. Conceivably, PA28
might stimulate additional rounds of hydrolysis of previously
digested, longer precursors. However, reentry into the protea-
some and further hydrolysis of already released fragments
seem statistically less likely because our degradation assays
were performed under conditions that have previously been
shown to allow generation of individual peptides at linear rates
for several hours (Cascio et al., 2001; Kisselev et al., 1999). To
this end, substrate was always present in large excess, and no
more than 10% of the protein was consumed at the end of the
incubation period, which ensured that peptides analyzed were
generated directly from the substrate and did not reenter the pro-
teasome and undergo cleavage in later rounds of proteolysis.
Likewise, it has been shown that in vitro peptides released by
proteasomes are further cleaved by these proteolytic particles
at extremely low rates (Saric et al., 2004), and they are therefore
unlikely to efficiently compete for degradation with proteins,
which are much more preferable as substrates (Dolenc et al.,
1998). Furthermore, if reuptake and further hydrolysis by 20S-
PA28ab immunoproteasomes of intermediate fragments had
occurred, they would have been expected to increase over
time as longer peptides were generated and their concentration
increased. Consequently, the kinetics of new amino group gen-
eration would most likely be exponential rather than linear
because intermediate fragments would be metabolized again
according to a double-cut modality, which implies release of
three free amino groups each time a long precursor is further
hydrolyzed (Dick et al., 1996). If intermediate products were
indeed generated, over time they would start to compete with
the protein substrates for hydrolysis at proteasomal active sites,
which in turn would cause a progressive decrease in the rates of
protein consumption, a phenomenon that we did not observed
even after prolonged incubation. As alternative possibilities,
PA28 might enhance generation of shorter products by inducing
conformational changes in proteasomal active sites or by
imposing a constraint on the exit port that would have a greater
effect on longer fragments. These fragments would be retained
inside the proteasomal proteolytic cavity longer and therefore
would have an increased probability of further cleavage. At the
present, neither of these two hypotheses can be controverted.
In fact, although crystallographic studies show that association
with PA26 does not induce structural modification of proteaso-
mal catalytic b subunits (Whitby et al., 2000), biochemical data
indicate that proteasomal proteolytic sites are allosterically regu-
lated (Harris et al., 2001; Li et al., 2000, 2001) and that their modi-
fication leads to gate opening (Osmulski and Gaczynska, 2000,
2002; Osmulski et al., 2009). Furthermore, an allosteric pathway
linking the PA26 binding sites with the active sites in the Thermo-
plasma acidophilum 20S proteasome has recently been
described (Ruschak and Kay, 2012). A model entailing PA28ab
in which it acts by imposing a constraint on diffusion of longer
products out of the hydrolytic chamber, thus facilitating their
further hydrolysis, is also consistent with our data. In this sce-
nario, PA28would primarily act as a sieve that retains longer pro-
tein fragments inside the 20S proteolytic chamber until they were
cleaved to pieces small enough to diffuse outside the chamber.
Such a molecular mechanism would be consistent with both
detailed kinetic analysis showing that PA28 exerts its activating470–480, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 475
(legend on next page)
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Figure 5. Modifications in Cleavage Specificities of 20S Immuno-
proteasomes Induced by PA28ab
(A) Chymotryptic, tryptic, and caspase activities of the PA28ab-20S im-
munoproteasome were measured with different fluorogenic peptides and are
indicated as fold change relative to the corresponding activities of the 20S
particle alone. Data are the average of three independent experiments (±SEM).
Below the graph, the values (±SEM) of specific activity for the hydrolysis of
each fluorogenic substrate by PA28ab-20S are reported. See also Supple-
mental Information.
(B) The grand average of hydropathy values for peptides preferentially
released from IGF-1 and casein by 20S and PA28ab-20S immuno-
proteasomes were calculated as described in Table S3.
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(three or four residues) (Stohwasser et al., 2000) and with a pre-
vious in vitro/in silico study that identified one of themajor factors
involved in the enhancement of double-cut efficiency induced by
PA28 in a reduced efflux of longer peptides out of the 20S parti-
cle (Mishto et al., 2008). Furthermore, it was recently shown that
a PA28ab complex lacking the unstructured and highly mobile
PA28a loops surrounding the central pore of the heptameric
ring cleaves substrates longer than a nonapeptide more effi-
ciently than wild-type PA28. On these bases, it was hypothe-
sized that the flexible loops of PA28 might act as gatekeepers
that block the exit of longer peptides from the proteolytic
chamber (Sugiyama et al., 2013). Selectivity based exclusively
on peptide size, however, cannot account for the global effects
of PA28 on the patterns of proteasome products observed in
our study. In fact, quantitation of products demonstrated that
several individual peptides with a length of 8 to 23 residues are
released in much higher amounts by PA28ab-20S than by 20SFigure 4. MS/MS Analysis of Peptides Generated from IGF-1 and Case
Peptides were identified by MS/MS, and those produced by more than one immu
as described in the Experimental Procedures section. Values are the percentag
derscored peptides are those whose generation requires removal of only one or tw
Chemistry & Biology 21,or 26S immunoproteasomes (Table S1). At present, the proper-
ties that might allow specific longer peptides to evade the
constraint imposed by PA28 toward their efflux are not
completely clear. However, the finding that products longer
than seven residues whose generation is strongly enhanced in
the presence of PA28 are, on average, more hydrophilic than
those preferentially released by 20S alone, suggesting that the
passage of polar and/or charged long peptides thorough PA28
might be favored. In this model, PA28 would act as a selective
‘‘smart’’ sieve that strictly controls the exit from proteasomes
of products on the basis of size and, presumably, sequence.
As a result, PA28ab would promote preferential efflux from the
20S proteolytic cavity of only a reduced number of individual
peptides longer than six or seven amino acids, whereas the great
majority of the other proteasomal products would be retained
inside, where they would further cleave to smaller pieces before
they diffused outside. In accordance with this model, the central
channel of the PA28a ring is almost completely lined by charged
or polar residues (Knowlton et al., 1997) and is thus well-suited
for permitting the passage of water-soluble peptides. Impor-
tantly, this molecular model would also be consistent with our
findings regarding 19S-20S-PA28 immunoproteasomes. In this
case, the absence of a clear difference in size distribution (Cas-
cio et al., 2002) supports the hypothesis that, in hybrid protea-
somes (as in 26S canonical particles), the main route of exit of
peptides from the inner proteolytic chamber is regulated by the
19S cap, whereas PA28 exerts its major effect by allowing
preferential sorting, through its central channel, of selected
products. Accordingly, hybrid particles were found to generate
some of the peptides produced in common by 26S and
PA28ab-20S from IGF-1, in addition to several of those released
specifically by only one of the two immunoproteasome forms.Implications for MHC Class I Antigen Presentation
The reasons why mammalian cells are equipped with different
immunoproteasome species and whether these immunoprotea-
somal variants play specific roles in the MHC class I antigen-
processing pathway are presently unknown. Yet, the in vivo
observation that their cellular levels greatly increase following
IFN-g stimulation (Murata et al., 2001; Tanahashi et al., 1997)
strongly supports their involvement in MHC class I presentation.
In this regard, themajor findings of our study can be summarized
as follows.
(1) For both protein substrates analyzed, only 10% of
peptides generated by 20S and 26S immunoprotea-
somes are eight to ten residues long, which is the appro-
priate length to bind MHC class I heterodimers. Most
importantly, association of PA28ab with the ends of 20S
immunoproteasomes does not increase the fraction of
the eight- to ten-residue peptides generated, but reduces
it to 6% of the total for both substrates.
(2) The fraction of peptides longer than ten amino acids,
which might serve in MHC class I antigen presentationin Degradation by 20S, 26S, and PA28ab-20S Immunoproteasomes
noproteasome species were quantified on the basis of their ion intensity signal
e of the highest ion intensity signal for each single peptide set as 100%. Un-
o residues at the N or C terminus of the substrate. See also Tables S1 and S2.
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cytosol or ER, is larger for 20S than for 26S immunopro-
teasomes. Binding of PA28ab to the 20S particle dramat-
ically reduces the overall efficiency of generation of these
longer products. We conclude, therefore, that PA28 does
not act simply by expending the fraction of proteasomal
products that can be accommodated in the groove of
MHC class I molecules directly or after trimming.
From an immunological point of view, however, the sequence
and not only the length of proteasomal products is a crucial
parameter. In the present study, the relative amounts of individ-
ual peptides produced by more than one immunoproteasomal
species from IGF-1 and casein were quantified on the basis of
their ion intensity signal following sequencing using MS/MS.
This analysis revealed striking quantitative differences, which
in several cases exceeded three orders of magnitude, thus
demonstrating that each immunoproteasomal form possesses
the capacity to preferentially release individual peptides in the
range of 8 to 25 residues. The outcome of this selection process
upon MHC class I presentation is further amplified by the fact
that, overall, the absolute generation of longer peptides was
reduced upon association with PA28, as shown by HP-SEC
analysis.
SIGNIFICANCE
Our study demonstrates that, in spite of their different gen-
eral efficiency in generating products with a size distribution
appropriate to serve in MHC class I presentation, 20S, 26S,
and PA28ab-20S immunoproteasomes possess the capac-
ity to produce exclusively, or at least in a preferential
manner, a subset of specific peptides. In this regard, the
finding that PA28ab induces generation of a certain number
of peptides with an acidic C terminus is counterintuitive
because these products cannot bind efficiently to MHC
class I molecules (Kloetzel, 2001; Pamer and Cresswell,
1998; Rock and Goldberg, 1999). However, several of the
remaining peptides do present the correct hydrophobic or
basic C-terminal anchor residue required for association
with the MHC class I groove. It seems plausible, therefore,
that a substantial fraction of peptides specifically released
by PA28ab-20S immunoproteasomes might be critical in
eliciting an effective CTL response under different patho-
physiological conditions, especially if favoring a noncanon-
ical, ubiquitin-independent proteolytic pathway (Orlowski
and Wilk, 2003; Qian et al., 2006; Yuksek et al., 2009). In
principle, it is also possible that, by promoting release of a
certain number of peptides that cannot serve in MHC class
I antigen presentation, PA28 might exert a regulatory func-
tion blunting excessive cytotoxic responses against anti-
gens of self-origin, thus preventing the risk of potentially
harmful autoimmune reactions.
EXPERIMENTAL PROCEDURES
Protein Purification, Substrate Degradation, and Peptide Analysis
Purification of immunoproteasomes and PA28ab, casein and IGF-1 degrada-
tion, and HPLC analysis of peptide products were performed as previously
described (Berko et al., 2012; Cascio et al., 2001, 2002; Song et al., 1997).478 Chemistry & Biology 21, 470–480, April 24, 2014 ª2014 ElsevierMore details are provided in the Supplemental Information. Heterodimeric
PA28 (Figure S1C) was reconstituted from purified recombinant a and b sub-
units as described previously (Song et al., 1997), with minor modifications.
Briefly, equal volumes of proteins at a final concentration of 0.1 mg/ml were
preincubated in 20 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic
acid (HEPES), pH 7.6, 20 mM NaCl, 1 mM EDTA, 5 mM b-mercaptoethanol,
and 5% glycerol for 16 hr at 4C. Reconstituted PA28ab complexes were
then purified by gel filtration on a HiPrep Sephacryl-S200 HR column (GE
Healthcare, Piscataway, NJ) (Figure S1D) and were free of any exo- or endo-
proteolytic activity. PA28ab-20S immunoproteasomes were reconstituted by
preincubating 20S particles with an 8-fold molar excess of PA28ab at 37C
for 30 min in 20 mM HEPES, pH 7.6, and 2 mM NaCl and were used immedi-
ately for degradation experiments. Native PAGE showed almost complete
conversion of 20S particles into doubly capped (PA28ab-20S-PA28ab) 20S
immunoproteasomes that were stable throughout the entire degradation
period (Figure S1A). For analysis of peptide products, casein (470 mM) and
denatured IGF-1 (900 mM) were incubated with 20S (20 nM IGF-1 and 50 nM
casein), PA28ab-20S (20 nM IGF-1 and 50 nM casein), and 26S immunopro-
teasomes (35 nM for both substrates) for 6 hr at 37C in 20 mM HEPES,
pH 7.6, 1.5 mM ATP, 3 mMMgCl2, and 2 mM NaCl. To assay peptides gener-
ated during protein degradation, we measured the appearance of new amino
groups using fluorescamine. At the end of the incubation, peptide products
were separated from undegraded protein by ultrafiltration through a mem-
brane with a 5 kDa cutoff, and these samples were used for HP-SEC and
MS/MS. Consumption of substrates at the end of the incubation never
exceeded 10% (Figure S2). FITC-casein (10 mM) was degraded by 20S,
PA28ab-20S, and 26S immunoproteasomes (40 nM) for 6 hr at 37C in
20 mM HEPES, pH 7.6, 1.5 mM ATP, 3 mM MgCl2, and 2 mM NaCl. At the
end of the incubation, undigested FITC-casein was precipitated with 2%
perchloric acid, and fluorescence in the supernatant was measured (excita-
tion, 490 nm; emission, 525 nm). RP-HPLC analysis of peptides generated
by different immunoproteasome species was performed using methods
described elsewhere (Cascio et al., 2002). For HP-SEC, equal amounts of
peptides generated during degradation of casein and IGF-1 were lyophilized,
resuspended in 0.1 M HEPES, pH 6.8, and separated on a polyhydroxyethyl
aspartamide column (0.463 20 cm; PolyLC, Columbia, MD). Themobile phase
consisted of 0.2 M Na2SO4 and 25% acetonitrile, pH 3.0, at a flow rate of
0.125 ml/min. For each analysis, 20 ml of peptide solution was added to
10 ml of fluorescamine (0.3 mg/ml in acetone). The reaction was terminated
after 30 s with 30 ml of H2O, and the sample was immediately injected onto
the HPLC column. The fluorescence of eluted material was monitored contin-
uously, and a blank run (corresponding to time 0) was always subtracted. To
determine the apparent molecular mass of peptides eluted, the column was
calibrated with 18 standard amino acids and peptides in the 200 to 3,500 Da
range that had been derivatized with fluorescamine in the same manner as
proteasomal degradation products. Prior control studies showed that the
retention times of these fluorescamine-derivatized products are highly repro-
ducible and linearly dependent on the logarithm of their molecular weights
(Figure S2) and that recovery of amino acids and peptides of different lengths
is quantitative. Note that amino acids and peptides eluted from the column are
bound to fluorescamine, whosemolecular weight must be subtracted to calcu-
late the actual mass of proteasomal products. Mean and median sizes of
peptides generated by immunoproteasomes were calculated from the distri-
butions of products obtained by HP-SEC, assuming an average molecular
weight of 110 Da for each residue. Proteasome peptidase activities were
measured using specific fluorogenic substrates in 20 mM Tris-HCl, pH 7.5,
1 mM ATP, 2 mM MgCl2, and 0.2% (w/v) BSA. The fluorescence of released
7-amino-4-methylcoumarin (excitation, 380 nm; emission, 460 nm) was moni-
tored continuously at 37C. Assayswere calibrated using standard solutions of
the free fluorophore, and the reaction velocities were calculated from the
slopes of the initial linear portions of the curves.
Tandem Mass Spectrometry of Proteasomal Products
Peptides generated by degradation of similar amounts of IGF-1 by immuno-
proteasomes and casein in two independent experiments were analyzed by
liquid chromatography-MS/MS. Peptides were captured on a C18 column
stage tip. The cleaned peptides were separated on a nano-HPLC system
(EASY-nLC; Proxeon/Thermo Fisher Scientific, West Palm Beach, FL) usingLtd All rights reserved
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Differences in Products of Immunoproteasomesa 5% to 40% linear gradient of acetonitrile on a 15-cmmicrocolumn (prepared
in house; 75-mm inner diameter, filled with 3-mm C18 reverse phase beads,
ReproSil column; Dr. Maisch, Ammerbuch-Entringen, Germany) and directly
sprayed into the mass spectrometer (LTQ Orbitrap or Q Exactive; Thermo
Fisher Scientific) using a Proxeon ion source. Data were analyzed using
version 1.3.0.5 of the MaxQuant software package (Cox and Mann, 2008).
Briefly, the software uses MS/MS spectra for the identification of peptides,
and quantification of peptides is derived from MS/MS spectra. The software
integrates the intensities over the entire range of elution, thus allowing highly
accurate quantification of peptides. The false discovery rate was set to 1%
of peptide levels.
Statistical Analyses
To compare average measures of amino group generation, protein degrada-
tion, and peptide hydrophilicity, we adopted a Mann-Whitney U test. Error
bars represent SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2014.02.006.
ACKNOWLEDGMENTS
We thank Marion Schmidt and Ernst Jarosch for critical reading of the manu-
script, and we are grateful to Patrick Moore for assistance in preparation of the
manuscript. This research was supported by the Italian Ministry of Instruction,
University and Research (MIUR) (PRIN 2008 to P.C.).
Received: July 25, 2013
Revised: December 20, 2013
Accepted: February 3, 2014
Published: March 13, 2014
REFERENCES
Ahn, K., Erlander, M., Leturcq, D., Peterson, P.A., Fru¨h, K., and Yang, Y. (1996).
In vivo characterization of the proteasome regulator PA28. J. Biol. Chem. 271,
18237–18242.
Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., and Kuster, B. (2007).
Quantitative mass spectrometry in proteomics: a critical review. Anal.
Bioanal. Chem. 389, 1017–1031.
Benaroudj, N., Zwickl, P., Seemu¨ller, E., Baumeister, W., and Goldberg, A.L.
(2003). ATP hydrolysis by the proteasome regulatory complex PAN serves
multiple functions in protein degradation. Mol. Cell 11, 69–78.
Berko, D., Tabachnick-Cherny, S., Shental-Bechor, D., Cascio, P., Mioletti, S.,
Levy, Y., Admon, A., Ziv, T., Tirosh, B., Goldberg, A.L., and Navon, A. (2012).
The direction of protein entry into the proteasome determines the variety of
products and depends on the force needed to unfold its two termini. Mol.
Cell 48, 601–611.
Cascio, P., Hilton, C., Kisselev, A.F., Rock, K.L., and Goldberg, A.L. (2001).
26S proteasomes and immunoproteasomes produce mainly N-extended
versions of an antigenic peptide. EMBO J. 20, 2357–2366.
Cascio, P., Call, M., Petre, B.M., Walz, T., and Goldberg, A.L. (2002).
Properties of the hybrid form of the 26S proteasome containing both 19S
and PA28 complexes. EMBO J. 21, 2636–2645.
Coux, O., Tanaka, K., and Goldberg, A.L. (1996). Structure and functions of the
20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–847.
Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-wide
protein quantification. Nat. Biotechnol. 26, 1367–1372.
de Graaf, N., van Helden, M.J., Textoris-Taube, K., Chiba, T., Topham, D.J.,
Kloetzel, P.M., Zaiss, D.M., and Sijts, A.J. (2011). PA28 and the proteasome
immunosubunits play a central and independent role in the production of
MHC class I-binding peptides in vivo. Eur. J. Immunol. 41, 926–935.Chemistry & Biology 21,Dick, T.P., Ruppert, T., Groettrup, M., Kloetzel, P.M., Kuehn, L., Koszinowski,
U.H., Stevanovic, S., Schild, H., and Rammensee, H.G. (1996). Coordinated
dual cleavages induced by the proteasome regulator PA28 lead to dominant
MHC ligands. Cell 86, 253–262.
Dolenc, I., Seemu¨ller, E., and Baumeister, W. (1998). Decelerated degradation
of short peptides by the 20S proteasome. FEBS Lett. 434, 357–361.
Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1992). Purification of an
11S regulator of the multicatalytic protease. J. Biol. Chem. 267, 22369–22377.
Groll, M., Bajorek, M., Ko¨hler, A., Moroder, L., Rubin, D.M., Huber, R.,
Glickman, M.H., and Finley, D. (2000). A gated channel into the proteasome
core particle. Nat. Struct. Biol. 7, 1062–1067.
Harris, J.L., Alper, P.B., Li, J., Rechsteiner, M., and Backes, B.J. (2001).
Substrate specificity of the human proteasome. Chem. Biol. 8, 1131–1141.
Hendil, K.B., Khan, S., and Tanaka, K. (1998). Simultaneous binding of PA28
and PA700 activators to 20S proteasomes. Biochem. J. 332, 749–754.
Kincaid, E.Z., Che, J.W., York, I., Escobar, H., Reyes-Vargas, E., Delgado,
J.C., Welsh, R.M., Karow, M.L., Murphy, A.J., Valenzuela, D.M., et al. (2012).
Mice completely lacking immunoproteasomes showmajor changes in antigen
presentation. Nat. Immunol. 13, 129–135.
Kisselev, A.F., Akopian, T.N., Woo, K.M., and Goldberg, A.L. (1999). The sizes
of peptides generated from protein by mammalian 26 and 20S proteasomes.
Implications for understanding the degradative mechanism and antigen
presentation. J. Biol. Chem. 274, 3363–3371.
Kloetzel, P.M. (2001). Antigen processing by the proteasome. Nat. Rev. Mol.
Cell Biol. 2, 179–187.
Knowlton, J.R., Johnston, S.C., Whitby, F.G., Realini, C., Zhang, Z.,
Rechsteiner, M., and Hill, C.P. (1997). Structure of the proteasome activator
REGa (PA28a). Nature 390, 639–643.
Ko¨hler, A., Cascio, P., Leggett, D.S., Woo, K.M., Goldberg, A.L., and Finley, D.
(2001). The axial channel of the proteasome core particle is gated by the Rpt2
ATPase and controls both substrate entry and product release. Mol. Cell 7,
1143–1152.
Li, J., Gao, X., Joss, L., and Rechsteiner, M. (2000). The proteasome activator
11S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligo-
merization and proteasome binding but not in the activation of specific protea-
some catalytic subunits. J. Mol. Biol. 299, 641–654.
Li, J., Gao, X., Ortega, J., Nazif, T., Joss, L., Bogyo, M., Steven, A.C., and
Rechsteiner, M. (2001). Lysine 188 substitutions convert the pattern of protea-
some activation by REGg to that of REGs a and b. EMBO J. 20, 3359–3369.
Li, J., Powell, S.R., andWang, X. (2011). Enhancement of proteasome function
by PA28a: overexpression protects against oxidative stress. FASEB J. 25,
883–893.
Ma, C.P., Slaughter, C.A., and DeMartino, G.N. (1992). Identification, purifica-
tion, and characterization of a protein activator (PA28) of the 20S proteasome
(macropain). J. Biol. Chem. 267, 10515–10523.
Mishto, M., Luciani, F., Holzhu¨tter, H.G., Bellavista, E., Santoro, A., Textoris-
Taube, K., Franceschi, C., Kloetzel, P.M., and Zaikin, A. (2008). Modeling the
in vitro 20S proteasome activity: the effect of PA28-ab and of the sequence
and length of polypeptides on the degradation kinetics. J. Mol. Biol. 377,
1607–1617.
Murata, S., Udono, H., Tanahashi, N., Hamada, N., Watanabe, K., Adachi, K.,
Yamano, T., Yui, K., Kobayashi, N., Kasahara, M., et al. (2001).
Immunoproteasome assembly and antigen presentation in mice lacking both
PA28a and PA28b. EMBO J. 20, 5898–5907.
Old, W.M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K.G., Mendoza, A.,
Sevinsky, J.R., Resing, K.A., and Ahn, N.G. (2005). Comparison of label-free
methods for quantifying human proteins by shotgun proteomics. Mol. Cell.
Proteomics 4, 1487–1502.
Orlowski, M., and Wilk, S. (2003). Ubiquitin-independent proteolytic functions
of the proteasome. Arch. Biochem. Biophys. 415, 1–5.
Osmulski, P.A., and Gaczynska, M. (2000). Atomic force microscopy reveals
two conformations of the 20S proteasome from fission yeast. J. Biol. Chem.
275, 13171–13174.470–480, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 479
Chemistry & Biology
Differences in Products of ImmunoproteasomesOsmulski, P.A., and Gaczynska, M. (2002). Nanoenzymology of the 20S
proteasome: proteasomal actions are controlled by the allosteric transition.
Biochemistry 41, 7047–7053.
Osmulski, P.A., Hochstrasser, M., and Gaczynska, M. (2009). A tetrahedral
transition state at the active sites of the 20S proteasome is coupled to opening
of the a-ring channel. Structure 17, 1137–1147.
Pamer, E., and Cresswell, P. (1998). Mechanisms of MHC class I-restricted
antigen processing. Annu. Rev. Immunol. 16, 323–358.
Pickering, A.M., Koop, A.L., Teoh, C.Y., Ermak, G., Grune, T., and Davies, K.J.
(2010). The immunoproteasome, the 20S proteasome and the PA28ab protea-
some regulator are oxidative-stress-adaptive proteolytic complexes.
Biochem. J. 432, 585–594.
Qian, S.B., Princiotta, M.F., Bennink, J.R., and Yewdell, J.W. (2006).
Characterization of rapidly degraded polypeptides in mammalian cells reveals
a novel layer of nascent protein quality control. J. Biol. Chem. 281, 392–400.
Rabl, J., Smith, D.M., Yu, Y., Chang, S.C., Goldberg, A.L., and Cheng, Y.
(2008). Mechanism of gate opening in the 20S proteasome by the proteasomal
ATPases. Mol. Cell 30, 360–368.
Rechsteiner, M., Realini, C., and Ustrell, V. (2000). The proteasome activator
11S REG (PA28) and class I antigen presentation. Biochem. J. 345, 1–15.
Rock, K.L., and Goldberg, A.L. (1999). Degradation of cell proteins and the
generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17,
739–779.
Ruschak, A.M., and Kay, L.E. (2012). Proteasome allostery as a population
shift between interchanging conformers. Proc. Natl. Acad. Sci. USA 109,
E3454–E3462.
Saric, T., Graef, C.I., and Goldberg, A.L. (2004). Pathway for degradation of
peptides generated by proteasomes: a key role for thimet oligopeptidase
and other metallopeptidases. J. Biol. Chem. 279, 46723–46732.
Shabek, N., and Ciechanover, A. (2010). Degradation of ubiquitin: the fate of
the cellular reaper. Cell Cycle 9, 523–530.
Sijts, A., Sun, Y., Janek, K., Kral, S., Paschen, A., Schadendorf, D., and
Kloetzel, P.M. (2002). The role of the proteasome activator PA28 in MHC class
I antigen processing. Mol. Immunol. 39, 165–169.480 Chemistry & Biology 21, 470–480, April 24, 2014 ª2014 ElsevierSong, X., von Kampen, J., Slaughter, C.A., and DeMartino, G.N. (1997).
Relative functions of the a and b subunits of the proteasome activator,
PA28. J. Biol. Chem. 272, 27994–28000.
Stadtmueller, B.M., and Hill, C.P. (2011). Proteasome activators. Mol. Cell 41,
8–19.
Stohwasser, R., Salzmann, U., Giesebrecht, J., Kloetzel, P.M., and Holzhu¨tter,
H.G. (2000). Kinetic evidences for facilitation of peptide channelling by the
proteasome activator PA28. Eur. J. Biochem. 267, 6221–6230.
Sugiyama, M., Sahashi, H., Kurimoto, E., Takata, S., Yagi, H., Kanai, K.,
Sakata, E., Minami, Y., Tanaka, K., and Kato, K. (2013). Spatial arrangement
and functional role of a subunits of proteasome activator PA28 in hetero-olig-
omeric form. Biochem. Biophys. Res. Commun. 432, 141–145.
Tanahashi, N., Yokota, K., Ahn, J.Y., Chung, C.H., Fujiwara, T., Takahashi, E.,
DeMartino, G.N., Slaughter, C.A., Toyonaga, T., Yamamura, K., et al. (1997).
Molecular properties of the proteasome activator PA28 family proteins and
g-interferon regulation. Genes Cells 2, 195–211.
Voges, D., Zwickl, P., and Baumeister, W. (1999). The 26S proteasome: a
molecular machine designed for controlled proteolysis. Annu. Rev. Biochem.
68, 1015–1068.
Whitby, F.G., Masters, E.I., Kramer, L., Knowlton, J.R., Yao, Y., Wang, C.C.,
and Hill, C.P. (2000). Structural basis for the activation of 20S proteasomes
by 11S regulators. Nature 408, 115–120.
Yamano, T., Sugahara, H., Mizukami, S., Murata, S., Chiba, T., Tanaka, K., Yui,
K., and Udono, H. (2008). Allele-selective effect of PA28 in MHC class I antigen
processing. J. Immunol. 181, 1655–1664.
Yao, T., and Cohen, R.E. (2002). A cryptic protease couples deubiquitination
and degradation by the proteasome. Nature 419, 403–407.
Yewdell, J.W. (2001). Not such a dismal science: the economics of protein
synthesis, folding, degradation and antigen processing. Trends Cell Biol. 11,
294–297.
Yuksek, K., Chen, W.L., Chien, D., and Ou, J.H. (2009). Ubiquitin-independent
degradation of hepatitis C virus F protein. J. Virol. 83, 612–621.
Zhang, Z., Realini, C., Clawson, A., Endicott, S., and Rechsteiner, M. (1998).
Proteasome activation by REG molecules lacking homolog-specific inserts.
J. Biol. Chem. 273, 9501–9509.Ltd All rights reserved
